Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation and destruction. 1 There is currently no cure – and although there are many treatments, their effectiveness ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the groundwork that may inform a new generation of therapeutic targets and ...

Microbial alterations have been reported in RA pathogenesis; however, data on the microbe type and their specific contributions to RA development are limited. About the review.

A study exploring the pathogenesis of rheumatoid arthritis (RA) has revealed an unsuspected role of B lymphocytes in a well-characterized mouse model of the disease the disease, the tumor necrosis ...

Rheumatoid arthritis (RA) is classified as seropositive or seronegative based on the presence of specific antibodies in the blood, which can influence the severity of symptoms and treatment ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an osteoarthritis treatment in human trials may have potential for treating RA.

The pathogenesis of RA is not yet completely understood; however, this chronic, systemic, autoimmune disease typically carries poor prognoses exacerbated by joint destruction, ...

Symptoms of RA vary and progress over weeks or months, often starting subtly on both sides of the body. Early RA symptoms include tenderness, pain, fatigue, and weakness, while later stages bring ...